MILESTONE PHARMACEUTICALS INC.

Transcripts Milestone Pharmaceuticals Inc.

Equities

MIST

CA59935V1076

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-10 pm EDT			5-day change	1st Jan Change
1.7 ^USD	0.00%		+0.59%	+1.80%

Apr. 08	Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients? Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting	CI
Mar. 28	Milestone Pharmaceuticals Resubmits Etripamil New Drug Application to FDA	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Milestone Pharmaceuticals Inc. - Shareholder/Analyst Call	Nov. 13
Transcript : Milestone Pharmaceuticals Inc. - Special Call	23-05-22
Transcript : Milestone Pharmaceuticals Inc. - Special Call	22-12-06
Transcript : Milestone Pharmaceuticals Inc. - Special Call	22-10-17
Transcript : Milestone Pharmaceuticals Inc. - Shareholder/Analyst Call	22-07-05
Transcript : Milestone Pharmaceuticals Inc. - Special Call	22-04-21
Transcript : Milestone Pharmaceuticals Inc. - Special Call	20-07-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW